300 results on '"Kaneko, Sakae"'
Search Results
2. Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study.
3. Verbal expressions describing itch quality in atopic dermatitis and urticaria: an online questionnaire survey in Japan
4. Physicians’ perspectives and practice in atopic dermatitis management: a cross-sectional online survey in Japan
5. Transient improvement of urticaria induces poor adherence as assessed by Morisky Medication Adherence Scale‐8
6. Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation
7. Poor adherence to medication as assessed by the Morisky Medication Adherence Scale‐8 and low satisfaction with treatment in 237 psoriasis patients
8. Disease perception in patients with atopic dermatitis and chronic spontaneous urticaria: a cross-sectional survey in Japan
9. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
10. MEFV variants are a predisposing factor for generalized pustular psoriasis
11. Approach for Aggravating Factors in Atopic Dermatitis
12. The thymus and activation-regulated chemokine (TARC) level in serum at an early stage of a drug eruption is a prognostic biomarker of severity of systemic inflammation
13. The ability of biomarkers to assess the severity of atopic dermatitis
14. Exploring patient background and biomarkers associated with the development of dupilumab-associated conjunctivitis and blepharitis
15. MEFV variants are a predisposing factor for generalized pustular psoriasis
16. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol
17. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid
18. Serum TARC levels are strongly correlated with blood eosinophil count in patients with drug eruptions
19. The ability of biomarkers to assess the severity of atopic dermatitis
20. Prevalence of human T-lymphotropic virus type I in patients with psoriasis and its effect on treatment choice: a multicenter observational study
21. Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study
22. Clinical characteristics of patients with psoriasis with family history: A multicenter observational study
23. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)
24. Simple and rapid detection of HLA-A*31:01 for prediction of carbamazepine-induced hypersensitivity using loop-mediated isothermal amplification method
25. Approach for Aggravating Factors in Atopic Dermatitis
26. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report
27. A Case of Family with Vörner-type Palmoplantar Keratoses Confirmed by Genetic Analysis
28. Serum Gliadin Monitoring Extracts Patients with False Negative Results in Challenge Tests for the Diagnosis of Wheat-Dependent Exercise-Induced Anaphylaxis
29. Adherence to oral and topical medication in 445 patients with tinea pedis as assessed by the Morisky Medication Adherence Scale-8
30. Usefulness of sentinel lymph node biopsy for the detection of metastasis in the early stage of extramammary Paget’s disease
31. Case of de novo psoriasis possibly triggered by nivolumab
32. Detection of refractive index changes in individual living cells by means of surface plasmon resonance imaging
33. Case of mucous membrane pemphigoid with immunoglobulin G antibodies to the beta 3 subunit of laminin-332 showing clinically Stevens–Johnson syndrome-like generalized blistering mucocutaneous lesions
34. Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens–Johnson syndrome and toxic epidermal necrolysis
35. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study).
36. SWEAT AND SWEAT ALLERGY AS AGGRAVATING FACTORS IN ATOPIC DERMATITIS: SYP01-7
37. Mycobacterium marinum infection in a case of psoriasis treated with antitumor necrosis factor α antibody detected by QuantiFERON®-TB test
38. Current status of the satisfaction levels of adult patients receiving drugs for atopic dermatitis and chronic urticaria
39. Takayasu arteritis developing during the course of palmoplantar pustulosis
40. Increase in serum IgE levels following injection of syngeneic keratinocyte extracts in BALB/c mice
41. Higher allergenicity of high molecular weight hydrolysed wheat protein in cosmetics for percutaneous sensitization
42. Neutrophilic dermatosis of the palms
43. HLA-A31 strongly associates with carbamazepine-induced adverse drug reactions but not with carbamazepine-induced lymphocyte proliferation in a Japanese population
44. QuantiFERON®-TB (QFT) test is a useful marker for cutaneous Mycobacterium marinum infection in a patient receiving adalimumab treatment: CS08-6
45. Successful treatment of acrodermatitis continua of Hallopeau with infliximab in a patient with hepatitis C virus infection: CS03-5
46. CD203c expression–based basophil activation test for diagnosis of wheat-dependent exercise-induced anaphylaxis
47. Interleukin-8 Levels in the Stratum Corneum as a Biomarker for Monitoring Therapeutic Effect in Atopic Dermatitis Patients
48. A case of wheat-dependent exercise-induced anaphylaxis sensitized with hydrolysed wheat protein in a soap
49. Missense mutation at the helix termination region in the 2B domain of keratin 14 in a Japanese family with epidermolysis bullosa simplex, generalized, other
50. Wound, pressure ulcer and burn guidelines – 1: Guidelines for wounds in general, second edition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.